Main navigation | Main content
The Medical Industry Leadership Institute is pleased to present this new and innovative educational opportunity. It's a fact that under-performing sales teams are responsible for the majority of under-performing companies. Excellence in research and design, engineering, accounting, finance, human resources, manufacturing, operations and marketing simply cannot make up for a sales team that is not executing.
In this course attendees will learn:
The target audience is executives and aspiring executives from medical device, bio technology, and pharmaceutical companies from start up's through Fortune 100. Leadership titles found in this audience include: CEO, COO, VP Sales, VP Marketing, VP Commercial Operations, Sales Director, Marketing Director, Regional Sales Manager, District Sales Manager and Sales Professionals progressing to leadership positions.
The course will be led by Brian Doughty, VP of Commercial Operations at Cardiovascular Systems headquartered here in the Twin Cities. He is a nationally recognized commercialization expert with 15 straight years of ranking in the top 5% of sales professionals and sales managers before becoming an executive. He has sold, managed, and built sales teams in a range of companies from Fortune 100 to start-ups. Mr. Doughty has Masters Degrees in Business Administration, Public Administration, and Psychology. He is a devoted student of both the science and psychology of sales and sales execution.
Dates: Saturday - November 3, 10, 17, December 1, 8, 15.
Time: 8:00 am-11:00 am
Location: Classroom in Carlson School of Management, 321 19th Avenue South, Minneapolis, MN
Cost: $2,000 per student
**This course will also be offered via web conference for remote participation.
Sessions will feature:
Susan Alpert, PhD, MD, MILI Executive in Residence
Stephen Parente, PhD, Director, Medical Industry Leadership Institute
Michael Ramlet, Director of Healthcare Policy, American Action Forum
Time: 12:00-1:00pm
Location: Carlson School of Management -- 2-219
321 19th Ave S, Minneapolis, MN 55455
If you are unable to attend in person we invite you to join the conversation via web conference. To participate in the meeting follow the links below
Date |
Link |
|---|---|
| September 24 | https://umconnect.umn.edu/mili-092412/ |
| October 29 | https://umconnect.umn.edu/mili-102912/ |
| November 26 | https://umconnect.umn.edu/mili-112612/ |
| December 17 | https://umconnect.umn.edu/mili-121712/ |
If you have never attended a Connect Pro meeting before:
Test your connection: https://umconnect.umn.edu/common/help/en/support/meeting_test.htm
Get a quick overview: http://www.adobe.com/go/connectpro_overview
Adobe, the Adobe logo, Acrobat and Acrobat Connect are either registered trademarks or trademarks of Adobe Systems Incorporated in the United States and/or other countries.
Wednesday September 26, 2012
11:30-1:00pm
Carlson School of Management - Room 1-132
321 19th Avenue S, Minneapolis
Pre-paid, or capitated payments to health care providers change incentives for treatment, and are widely used in a variety of settings including global budgets and ACO models. Certain forms of capitated payments, such as case-rate payments, create incentives to change both diagnosis and treatment patterns that may differ from both fee-for-service and pure capitated models. The purpose of this study is to examine the changes in severity determination and service use associated with changes in case-rate payments used to pay for publicly-funded mental healthcare. We model provider-assigned severity categories as a function of category-specific capitated payments using conditional logit regressions and counts of service days per month using hurdle models. We find that severitydetermination is only weakly associated with price but that level of use shows a greater degree of association; these results vary between the early or “transition” period immediately after implementation to the subsequent period, 2-4 years after implementation.
Marisa Domino, Ph.D., is a Professor of Health Economics in the Department of Health Policy and Management at the University of North Carolina at Chapel Hill. She received her Ph.D. in Health Economics from the Johns Hopkins University and completed a Postdoctoral Fellowship in the economics of mental health at Harvard Medical School’s Department of Health Care Policy. Dr. Domino’s research interests include the economics of mental health, agency relationships among physicians, patients and insurers, the diffusion of new technologies, and the public provision of health care and health insurance to low income populations. She is working on a number of projects evaluating innovations in clinical practice, including examining the incentives of medical homes on persons with chronic illnesses, and drug-based registries for children on antipsychotic medications.
This seminar is free and open to the public, RSVP is not required.
Co-sponsored by the Department of Health Policy & Management, School of Public Health, U of MN
The Impact of Health Reform on Medical Innovation and the Medical Industry
This LifeScience Alley Program on October 25th, will feature Stephen T. Parente, PhD, Director, Medical Industry Leadership Institute, Professor and Minnesota Insurance Industry Chair of Health Finance, Department of Finance speaking on a health reform microsimulation model, which is currently informing members of Congress and the Office of Actuary at Medicare/CMS. Included in the presentation will be the likely effect of legislation on the uninsured as well an assessment of which states may consider not participating in the Medicaid expansion due to budgetary issues. Finally, provider pricing and medical technology reimbursement and research and development will be considered as a direct consequence of health reform coming fully online in 2014.
For information on previous events not listed, please contact MILI at mili@umn.edu.
This talk will focus on what new production technologies are being implemented, and the movement of the production development process upstream through concurrent engineering. Paur will go in depth into the implications of these technologies and the short and long term effects of the concurrent engineering approach. Two main areas will be explored. First, new and emerging technologies in production and testing equipment that are being used in the medical realm. This includes laser technology, multi-axis motion control, vision-guided machinery, etc. The second is the shift from "siloed" production development to an integrated approach, leading us from product design through machine building, to validation and finally to production development. Paur will explore the integration process as well as the benefits of this approach.
Justin Paur is from a small farm in North Dakota, he has degrees in Mechanical and Aerospace Engineering, and is currently finishing up his MBA at Carlson. Paur has set up medical production on three continents, including Asia where he lived for six months. He currently works for a production development company, NACS, who is a master supplier to the largest medical device companies in the world.
This seminar is free and open to the public, RSVP is not required. If you cannot attend in person you can participate online via UMConnect at: https://umconnect.umn.edu/mili_paur_7_18_12/

Professor Chengli Song, Executive Director
Shanghai Institute for Minimally Invasive Therapy
University of Shanghai Science and Technology
Keynote Speaker and Panelist Bios here
A copy of Dr. Song's presentation can be found here.
This event will provide insight into China's booming medical device industry. Universities, government agencies and private companies all play a role in fostering medical innovation in China. Join us to discuss opportunities in this developing market for U.S. companies. Hear experts from the U.S. and China share lessons for mutual learning and collaboration. This program will also showcase the new multi-disciplinary approach to medical innovation used by the University of Shanghai for Science and Technology (USST).
Event Agenda:
| 8:00 a.m. - 8:30 a.m. | Registration and continental breakfast |
| 8:30 a.m. - 9:30 a.m. | Introductions and keynote address |
| 9:30 a.m. - 9:40 a.m. | BREAK |
| 9:40 a.m. - 10:50 a.m. | Panel discussion |
| 10:50 a.m. - 11: 10 a.m. | Q & A |
| 11:10 a.m. - 11:30 a.m. | Wrap-up/closing by Steve Parente |
Co-sponsored by the Center for International Business Education and Research (CIBER) and LifeScience Alley.
Thursday April 26, 2012 - 3:00-4:30pm
Carlson School of Management -- Room 2-206
321 19th Avenue S, Minneapolis
Provider-based research networks (PBRNs), such as the National Cancer Institute's Community Clinical Oncology Program (CCOP), make clinical trials available in community-based practice settings, but provider participation requires both financial and in-kind contributions. As the lack of a business case may result in provider reluctance to participate in PBRNs, knowledge of the financial and non-financial benefits may be crucial to encouraging and sustaining provider participation, thereby preserving patient access to innovative community-based treatments. Using a comparative, case-study approach we explored whether providers believe there is a business case for participating in PBRNs, and what factors contribute to the business case for hospitals attempting to support a PBRN research infrastructure. We then applied the key themes related to the business case to develop an EXCEL-based model to measure the return on investment to a hospital from investing in the CCOP. Providing a method for documenting the business case for CCOP involvement may contribute to the long-term sustainability and expansion of these programs by improving providers' understanding of the financial implications of participation. This research was supported by the National Cancer Institute.
Prior to joining the faculty at Ohio State, Dr. Song received her Ph.D. in health services organization and policy from the University of Michigan. She also holds a Master of Health Services Administration as well as a Masters of Arts in Applied Economics, both from the University of Michigan, and holds a Bachelor of Arts in Biological Basis of Behavior from the University of Pennsylvania. Dr. Song's research interests and publications cover areas such as health care financial management, investment strategies in not-for-profit hospitals and business case evaluation for health initiatives. Her research has been funded by the Centers for Health Care Management and Research, Agency for Healthcare Research and Quality, and the National Cancer Institute. She teaches graduate level courses in health care finance and is co-author on a leading textbook, Essentials of Health Care Finance, 7th Edition. Prior to academia, Dr. Song gained management expertise at Ochsner Health Care in New Orleans, Louisiana and has served as a health care finance consultant to hospitals and research organizations.
This seminar is free and open to the public.
Co-sponsored by the Department of Health Policy & Management, School of Public Health, U of MN
The University of Minnesota's Medical Devices Center, part of the Institute for Engineering in Medicine, the College of Science and Engineering, and the Academic Health Center present the 11th Annual Design of Medical Devices Conference. The conference will be held at The University Hotel Minneapolis (formerly Radisson University Hotel), located at 615 Washington Ave. SE, Minneapolis, Minnesota 55414, adjacent to the University of Minnesota campus.
Conference Goals
For more information go to: www.dmd.umn.edu
Monday March 19, 2012 - 2:00-3:30pm
Carlson School of Management -- Room 2-206
321 19th Avenue S, Minneapolis
For this seminar, Dr. Chernew will provide updated research analysis on the second phase of the study described below, which appeared in the New England Journal of Medicine, published online July 13, 2011.
In 2009, Blue Cross Blue Shield of Massachusetts implemented a global payment system called the Alternative Quality Contract (AQC). Provider groups in the AQC assume accountability for spending, similar to Accountable Care Organizations that bear financial risk. Moreover, groups are eligible for quality bonuses. Analyzed were 2006-2009 claims for 380,142 enrollees whose primary care physicians (PCPs) were in the AQC (intervention) and 1,351,446 enrollees whose PCPs were not (control). Findings showed that average spending increased for both AQC and non-AQC enrollees in 2009, but the increase was smaller for AQC enrollees. Savings largely derived from shifts in outpatient care toward facilities with lower fees, from procedures, imaging, and tests, and from subjects with highest expected spending. All AQC groups met 2009 budget targets and earned surpluses. Total BCBS payments to AQC groups, including quality bonuses, likely exceeded the estimated year-1 savings. The AQC was associated with modest slowing of spending growth and improved quality in 2009. The long-run AQC impact on spending growth depends on future budget targets and providers' ability to further improve efficiencies in practice.
Dr. Chernew's research examines several areas related to controlling health care spending growth while maintaining or improving the quality of care. He received his B.A. from the University of Pennsylvania, and his PhD in economics from Stanford University, where his training focused on areas of applied microeconomics and econometrics. He is the Co-Editor of the American Journal of Managed Care and Senior Associate Editor of Health Services Research. Dr. Chernew has served on the Editorial Boards of Health Affairs and Medical Care Research and Review. Dr. Chernew is also a Research Associate of the National Bureau of Economic Research. Dr. Chernew is a member of the Medicare Payment Advisory Commission (MedPAC), which is an independent agency established to advise the U.S. Congress on issues affecting the Medicare program. He is also a member of the Congressional Budget Office's Panel of Health Advisors, the Institute of Medicine's Committee on Determination of Essential Health Benefits, and The Commonwealth Foundation's Commission on a High Performance Health Care System.
This seminar is free and open to the public.
Co-sponsored by the Department of Health Policy & Management, School of Public Health, U of MN
Join MILI for our monthly "Lunch and Learn" series. Hear the latest from health economists who advise democrats and republicans that share a fair bit of common ground on future Medicare legislative proposals.
Discussion led by:
Recording of March 19th session:

Bradley Herring, PhD
Associate Professor, Johns Hopkins Bloomberg School of Public Health
Thursday February 2, 2012 - 3:00-4:30pm
Carlson School of Management - Room 2-224
321 19th Avenue S, Minneapolis
Do workers bear the cost of health insurance premiums in the form of lower wages? Herring will present work in which he and his colleagues conduct an empirical test of this question by examining how changes in premiums over time affect changes in wages - focusing on full-time workers who remain in the same job providing insurance to alleviate the problem of unobserved differences between jobs that do or do not offer insurance. Using a sample of wage-earners from the four-year 2004 panel of the Survey of Income and Program Participation linked to data on average employer contributions to premiums from the Medical Expenditure Panel Survey's Insurance Component across industry groupings within each state and controlling for worker and firm characteristics, they indeed observe a significantly negative effect of changes in employer-paid health insurance premiums on changes in worker wages. Herring will then highlight the policy significance of this wage/benefit tradeoff by discussing the implications of two particular provisions of the 2010 Affordable Care Act - the 2014 "play or pay" requirement that employers with more than 50 worker offer health benefits and the 2018 "Cadillac Tax" on high-cost plans.
Bradley Herring is a health economist at Johns Hopkins University whose research focuses on private and public health insurance. His work has been published in the Journal of Health Economics, Health Affairs, and New England Journal of Medicine, and it has been funded by the Robert Wood Johnson Foundation, HHS ASPE, and AHRQ. He received his Ph.D. in health economics from the University of Pennsylvania's Wharton School, did a health policy fellowship at Yale University, and served with the White House Council of Economic Advisers.
This seminar is free and open to the public.
Co-sponsored by the Department of Health Policy & Management, School of Public Health, U of MN
A Medical Device Development Journey: Using a life tragedy to eradicate needless death due to heart disease

Marie Johnson, PhD
President and CEO, AUM Cardiovascular
Tuesday December 6, 2011
Dr. Marie Johnson has created an innovative non-invasive handheld device to assess risk of coronary heart disease. She will share her journey as she traveled through different stages of her business, from idea to development. Dr. Johnson will discuss some of the successes and pitfalls she has encountered as well as share tips she has learned along the way. Recently, AUM Cardiovascular won the Grand Prize at the 2011 Minnesota Cup as well as first prize in the BioSciences Division.
Dr. Marie Johnson has 25 years of experience in product development and manufacturing in both university and Fortune 500 companies. She also led the development of a University of Minnesota think tank training post-doctoral engineers and medical doctors. Over the course of 2 years these teams created 32 medical device provisional patents, two licensing deals and two start-up companies. Dr. Johnson was trained by Josh Makower, MD and Paul Yock, MD as a post-doctoral fellow in the highly regarded biodesign program at Stanford University. Dr. Johnson has patents and patents pending in the United States, Europe and Taiwan in diagnosis of coronary artery disease, acetabular joint fixation, cardiac auscultation to analyze and diagnose heart sounds using signal processing methods, a powdered metal-based pressure indicator, stroke detection, fetal monitoring techniques, uterine fibroids, stuttering and noninvasive detection of atrial fibrillation.
John Stenson, FSA, MAAA
Senior Vice President and Chief Actuary, Kaiser Permanente
May 6, 2011
Benefits and Burdens of FDA Regulations on Global Medical Technology Markets
Keynote Speaker: Susan Alpert, Ph.D., M.D., Senior Vice President, Global Regulatory Affairs, Medtronic
Time: 8:00 - 11:30 a.m.
Location: Carlson School of Management, 3M Auditorium – Minneapolis, Minnesota
Co-sponsored by the Center for International Business Education and Research (CIBER)
This event will provide an insightful and candid set of conversations about the challenges facing the medical technology market and the evolving role of governments across the globe. This seminar is free and open to the public. Registration is required.
View full event information (pdf)
Podcast from "Benefits and Burdens of FDA Regulations on Global medical Technology Markets," held on May 6, 2011 is now available.
Keynote address
Download
Instant Play
Panel Discussion
Download
Instant Play
May 10, 2011
Death by Market Power: Reform, Competition and Patient Outcomes
in the National Health Service
Carol Propper, PhD
Chair in Economics, Imperial College Business School, Imperial College London
and University of Bristol
April 27, 2011
On the Determinants of Organizational Forgetting
Guy David, PhD, Assistant Professor of Health Care Management,
Wharton School, University of Pennsylvania
Time: 3:00-4:30
Location: Carlson School of Management room 2-206
March 9, 2011
Transforming the Health Care Delivery System from Within: HealthEast’s Care Navigation Journey
Rahul Koranne, MD, MBA, FACP
Medical Director, HealthEast Bethesda Hospital, Care Navigation & Home Care
3:00-4:30 pm
Herbert M. Hanson Hall, University of Minnesota
1925 4th Street S, Minneapolis
Room 1-111
November 22, 2010
MILI Actuarial Seminar: "Interesting Times for an Actuary: Healthcare Trends and Healthcare Reform"
M. Kent Clemens, FSA
Senior Actuary, Centers for Medicare and Medicaid Services (CMS), Office of the Actuary
Medicaid, Medicare, and total U.S. healthcare spending have received a lot of attention throughout the drive to healthcare reform. The recently-passed legislation will bring about change, but where do things stand before the reform begins? What are the expected impacts of the recently-passed healthcare reform legislation on Medicaid, Medicare, and total healthcare spending? What role have actuaries played along the way? (Actuaries are not just calculators!) View full event information (PDF).
November 8, 2010
"Nurses and Unionization"
Joanne Spetz, PhD, Professor of Community Health Systems, School of Nursing & Center for the Health Professions, University of California, San Francisco
Co-sponsored by the Department of Health Policy & Management, School of Public Health, U of MN
Nurses and Unionization Presentation (PDF)
May 26, 2010
"Understanding Health Insurance"
Katherine Baicker, PhD, Professor of Health Economics at Harvard School of Public Health
Co-sponsored seminar with the Department of Health Policy and Management, SHP
April 13-15, 2010
Design of Medical Devices Conference
Keynote Speakers Included:
April 30, 2010
"Technology Growth and Expenditure Growth in Healthcare"
Jonathan Skinner, PhD
John Sloan Dickey Third Century Professor of Economics
Dartmouth College
Co-sponsored seminar with the Department of Health Policy and Management, SPH
February 18, 2010
"Individual Health Insurance Reform without Side Effects"
Presented by Mark Pauly, PhD, Professor in the Department of Healthcare Management, Professor of Healthcare Management, Insurance and Risk Management, and Business and Public Policy at the Wharton School and Professor of Economics in the School of Arts and Sciences at the University of Pennsylvania
If you were unable to attend this seminar, you can view it here.
Co-sponsored seminar with the Department of Health Policy and Management, SPH
February 5, 2010
"MRI Equipment Ownership, MRI Use, and Effects of MRI on Total Healthcare Costs"
Laurence Baker, Professor of Health Research and Policy at Stanford University
Co-sponsored seminar with the Department of Health Policy and Management, SPH
Date |
Discussion led by |
Recording |
| August 27 | Stephen T. Parente, PhD, Director, Medical Industry Leadership Institute, Professor and Minnesota Insurance Industry Chair of Health Finance, Department of Finance |
|
| July 23 | Susan Alpert, PhD, MD, MILI Executive in Residence Michael Ramlet, Director of Healthcare Policy, American Action Forum
*Please note there were technical difficulties with this recording. The volume varies between very quiet (Susan Alpert) to very loud (Michael Ramlet). |
|
| March 19th | Michael Chernew, PhD, Professor of Health Care Policy, Department of Health Care Policy, Harvard Medical School Stephen T. Parente, PhD, Director, Medical Industry Leadership Institute, Professor and Minnesota Insurance Industry Chair of Health Finance, Department of Finance Susan Alpert, PhD, MD, MILI Executive in Residence |
Apple Devices: All Other Devices: Download Link or |
| April 16th | Stephen T. Parente, PhD, Director, Medical Industry Leadership Institute | Apple devices: All Other Devices: Download Link or |
At the recent American Society of Health Economists meeting at the Carlson School, Kerri Miller of MPR moderated a discussion on health reform. The conversation included Jonathan Gruber, professor of economics at MIT and Stephen Parente. Link to program audio here.